Polymerization of tau peptides into fibrillar structures.: The effect of FTDP-17 mutations

被引:105
|
作者
Arrasate, M [1 ]
Pérez, M [1 ]
Armas-Portela, R [1 ]
Avila, J [1 ]
机构
[1] UAM, Fac Ciencias, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain
关键词
tau; polymer; taupathy;
D O I
10.1016/S0014-5793(99)00210-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The peptides corresponding to the four repeats found in the microtubule binding region of tau protein were synthesized and their ability for self-aggregation in presence of heparin or chondroitin sulfate was measured. Mainly, only the peptide containing the third tau repeat is able to form polymers in a high proportion. Additionally, the peptide containing the second repeat aggregates with a very low efficiency, However, when this peptide contains the mutation (P301L), described in a fronto temporal dementia, it is able to form polymers at a higher extent. Finally, it is suggested to have a role for the first and fourth tau repeats. It could be to decrease the ability of the third tau repeat for self-aggregation in the presence of heparin, (C) 1999 Federation of European Biochemical Societies.
引用
收藏
页码:199 / 202
页数:4
相关论文
共 50 条
  • [1] Effects of FTDP-17 mutations of tau on the functions of tau.
    Licher, F
    Barghorn, S
    von Bergen, M
    Zheng-Fischhofer, Q
    Ackmann, M
    Wiech, H
    Mandelkow, EM
    Mandelkow, E
    MOLECULAR BIOLOGY OF THE CELL, 1999, 10 : 374A - 374A
  • [2] Tau gene mutations:: dissecting the pathogenesis of FTDP-17
    Ingram, EM
    Spillantini, MG
    TRENDS IN MOLECULAR MEDICINE, 2002, 8 (12) : 555 - 562
  • [3] Fibrillogenesis of tau: Insights from tau missense mutations in FTDP-17
    Yen, SH
    Hutton, M
    DeTure, M
    Ko, LW
    Nacharaju, P
    BRAIN PATHOLOGY, 1999, 9 (04) : 695 - 705
  • [4] FTDP-17 tau mutations decrease the susceptibility of tau to calpain I digestion
    Yen, S
    Easson, C
    Nacharaju, P
    Hutton, M
    Yen, SH
    FEBS LETTERS, 1999, 461 (1-2) : 91 - 95
  • [5] The effect of tau genotype on clinical features in FTDP-17
    Baba, Y
    Tsuboi, Y
    Baker, MC
    Uitti, RJ
    Hutton, ML
    Dickson, DW
    Farrer, M
    Putzke, JD
    Woodruff, BK
    Ghetti, B
    Murrell, JR
    Boeve, BF
    Petersen, RC
    Verpillat, P
    Brice, A
    Delisle, MB
    Rascol, O
    Arima, K
    Dysken, MW
    Yasuda, M
    Kobayashi, T
    Sunohara, N
    Komure, O
    Kuno, S
    Sperfeld, AD
    Stoppe, G
    Kohlhase, E
    Pickering-Brown, S
    Neary, D
    Bugiani, O
    Wszolek, ZK
    PARKINSONISM & RELATED DISORDERS, 2005, 11 (04) : 205 - 208
  • [6] Dephosphorylation of FTDP-17 mutant tau
    Asada, Akiko
    Yotsumoto, Kensuke
    Saito, Taro
    Oikawa, Takayuki
    Ishiguro, Koichi
    Uchida, Takafumi
    Hasegawa, Masato
    Hisanaga, Shin-Ichi
    NEUROSCIENCE RESEARCH, 2008, 61 : S263 - S263
  • [7] Missense tau mutations identified in FTDP-17 have a small effect on tau-microtubule interactions
    DeTure, M
    Ko, LW
    Yen, S
    Nacharaju, P
    Easson, C
    Lewis, J
    van Slegtenhorst, M
    Hutton, M
    Yen, SH
    BRAIN RESEARCH, 2000, 853 (01) : 5 - 14
  • [8] Pathogenic implication of altered tau properties caused by FTDP-17 mutations
    Nacharaju, P
    Yen, S
    Deture, M
    Easson, C
    Hutton, M
    Yen, SH
    ALZHEIMER'S DISEASE: ADVANCES IN ETIOLOGY, PATHOGENESIS AND THERAPEUTICS, 2001, : 621 - 629
  • [9] FTDP-17 and phosphorylation mimicking mutations in tau alter tau-fyn interaction
    Bhaskar, K
    Lee, G
    NEUROBIOLOGY OF AGING, 2004, 25 : S425 - S425
  • [10] Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)
    Spillantini, MG
    Van Swieten, JC
    Goedert, M
    NEUROGENETICS, 2000, 2 (04) : 193 - 205